
Ardent Health, Inc. (NYSE: ARDT) has announced the pricing of the previously announced secondary public offering (the Offering) of 8,000,000 shares of its common stock, consisting of 7,136,719 shares of its common stock by an affiliate of Equity Group Investments and 863,281 shares of its common stock by an affiliate of Ventas, Inc. (together, the Selling Stockholders) at a price to the public of US$14.50 per share. In connection with the Offering, the Selling Stockholders granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of common stock at the public offering price, less the underwriting discounts and commissions. The Offering is expected to close on November 19, 2026, subject to customary closing conditions.
Latham & Watkins LLP represents the underwriters in the offering with a Capital Markets team led by New York partners Nathan Ajiashvili and Erika Weinberg and New York counsel Lindsey Mills, with associates Matthew Dwelle and Renad Alqarni.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record

